By rotating special magnetic nanoparticles injected into brain tumors, a team of scientists led by Northwestern Medicine neurosurgical oncologist Maciej (Matt) Lesniak, MD, successfully damaged tumor cells in animal models.
HIV still replicates in lymphoid tissue, even when it is undetectable in the blood of patients on antiretroviral drugs, according to new Northwestern Medicine research.
Scientists showed that it is possible to specifically modify gene expression in diseased upper motor neurons in a new Northwestern Medicine translational study.
Rui Yang, a graduate student in the Driskill Graduate Program, studied the chromatin structure and expression of the gene that, when mutated, causes cystic fibrosis.
A recent study led by Elizabeth Perlman, MD, discovered a new genetic mutation in the most common type of pediatric kidney cancer, Wilms tumor.
Research conducted in the laboratory of Derek Wainwright, PhD, assistant professor of Neurological Surgery, explores strategies to reverse pathways that inhibit the body’s immune system from fighting glioblastoma.
Northwestern Medicine scientists have received a five-year, $11 million grant from the National Institutes of Health National Cancer Institute (NCI) to lead a Specialized Program of Research Excellence (SPORE) in prostate cancer.
A brain region controlling whether we feel happy or sad, as well as addiction, is remodeled by chronic pain, according to a new Northwestern Medicine study, and a new treatment targeting this region may dramatically lessen symptoms.
Douglas Wilcox, a student in the Medical Scientist Training Program, discovered the herpes simplex virus targets a host cell protein to cause severe disease and encephalitis in newborns.
A specially developed nanoparticle may be able to prevent progression of multiple sclerosis triggered by the death of brain cells that make the insulation around nerve fibers.
Notifications